eMolecules strengthens its strategic customer and supplier relationship teams

SAN DIEGO -- eMolecules is pleased to announce the addition of three new members to its senior leadership team.  Paul Burke, formerly of Novartis, joins as Vice President of Procurement; Kemberlyn Wuerfel, formerly of ThermoFisher, joins as Vice President Strategic Partnerships, US; and Paul Edgard Clémençon, formerly of VWR, joins as Vice President Strategic Partnerships, Europe. Paul Burke brings over [...]

Scientist at Mass General Cancer Center and Harvard Medical School Awarded xCELLigence Immunotherapy Research Grant

With the goal of developing a novel immunotherapy for patients with glioblastoma, the research grant winner will employ xCELLigence Real Time Cell Analysis technology to develop armored CAR-T cells   XCELLIGENCE IMMUNOTHERAPY RESEARCH GRANT WINNER DR. BRYAN CHOI IS A POSTDOCTORAL FELLOW WITH DR. MARCELA V. MAUS IN THE MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER AND [...]

Agilent Introduces Groundbreaking UV-Vis Spectrophotometer for Pharmaceutical, Biomedical, and Academic Laboratories

Cary 3500 UV-Vis system can run multiple experiments simultaneously, boosting laboratory efficiency SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today introduced the Cary 3500 UV-Vis system, an innovative spectrophotometer designed to help life science, pharma and biopharma research communities simplify their analyses, optimize laboratory productivity, and ultimately help bring new therapeutics to market faster. [...]

Precipio And PerkinElmer Collaborate To Provide Solutions For Liquid Biopsy Testing Workflows

Precipio ICE COLD-PCR™ reagents will be sold with PerkinElmer DNA/RNA extraction and isolation products NEW HAVEN, CT - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced an agreement with PerkinElmer to jointly offer Precipio’s ICE COLD-PCR (ICP) mutation enrichment technology together with PerkinElmer’s NextPrep-Mag™ cell-free DNA isolation kit, Janus® G3 liquid handling workstation, and chemagic™ MSM [...]

Sirona Dx Introduces Imaging Mass Cytometry Services to Advance Biomarker Discovery and Therapeutic Development

Specialized CRO offers high-definition tissue imaging services for pharmaceutical and clinical research SOUTH SAN FRANCISCO, Calif. and PORTLAND, Ore. -- Sirona Dx, a leader in high-complexity genomics and proteomics services, today announced the introduction of Imaging Mass Cytometry™ services on the Fluidigm Hyperion™ Imaging System to advance biomarker discovery and therapeutic development. Sirona Dx is a specialized [...]

Horizon Discovery partners with Biocartis to provide reference standards for recently launched Idylla™ microsatellite instability assay

First commercially available reference standard for microsatellite instability (MSI) testing Horizon Discovery’s reference material covers seven new MSI markers tested for on the Idylla™ platform MSI is a form of genetic instability that is predominantly found in colorectal, gastric and endometrial cancer and serves as a prognostic, diagnostic and predictive marker in the clinic  Cambridge, [...]

Olympus SpinSR10 Super Resolution Imaging System with Improved Efficiency Delivers Clearer Images, Reduced Phototoxicity and is 3X Brighter

The Olympus high-sensitivity SpinSR10 super resolution microscope combines fast 0.005 seconds/frame acquisition speed and 120-nanometer super resolution with improvements that provide clearer images and three times the brightness of the standard SpinSR10 model. Super resolution microscopes are used in medical and biological research to observe the internal structure of cells in fine detail, and brightness [...]

Agena Launches Bone Marrow Engraftment Assay For Chimerism Analysis

San Diego, CA – Agena Bioscience, a global provider of molecular testing solutions, today announced the release of the Chimeric ID Panel designed to reduce the time and cost of performing chimerism analysis for bone marrow engraftment monitoring studies. The SNP-based panel is designed for research use with the MassARRAY® system and is accompanied by software [...]

ERS GENOMICS LICENSES CRISPR GENE EDITING TECHNOLOGY TO DEFINIGEN TO DEVELOP HUMAN CELL MODELS TO SUPPORT THE PRECLINICAL DEVELOPMENT OF THERAPEUTICS

Dublin, Ireland, and Cambridge, UK – ERS Genomics Limited and DefiniGEN Ltd announced today a license agreement to provide DefiniGEN with access to ERS Genomic’s CRISPR/Cas9 genome editing technology patents. DefiniGEN will combine their best-in-class iPSC (induced Pluripotent Stem Cell) differentiation platform with CRISPR/Cas9 technology to generate a range of innovative preclinical human models. “The company’s [...]

CALIBRE SCIENTIFIC ACQUIRES KALON BIOLOGICAL AND CLIN-TECH, LEADING PROVIDERS OF IVD MEDICAL DEVICES AND MEDICAL DIAGNOSTIC KITS

Los Angeles, CA  – Calibre Scientific is pleased to announce that it has completed the acquisition of Kalon Biological Limited and Clin-Tech Limited (together “KalonBio“ or the “Company”). The Company specializes in the development and manufacture of a range of medical diagnostic kits, commercial ELISA (enzyme immunoassays [EIA]) kits and reagents for the healthcare and [...]

Access IBO on Knowledge Center